Systemic Anti-Cancer Therapy (SACT) data standard FHIR IG
0.5.0 - ci-build New Zealand flag

Systemic Anti-Cancer Therapy (SACT) data standard FHIR IG - Local Development build (v0.5.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Table of Contents

0 Table of Contents
1 Home
2 Api Input
3 Api Query
4 Architecture
5 Examples
6 Extensions
7 History
8 Profiles
9 Reference Implementation
10 Resource Graph
11 Terminology
12 Artifacts Summary
12.1 CapabilityStatement representing the server requirements for a FHIR server
12.2 an-supporting-info
12.3 ACT-NOW diagnosis
12.4 ACT-NOW medication administration
12.5 ACT-NOW medication request
12.6 ACT-NOW patient
12.7 Body Surface Area
12.8 Clinical M-score
12.9 Clinical N-score
12.10 Clinical T-score
12.11 Clinical TNM group score
12.12 Creatinine Clearance
12.13 Cycle Careplan
12.14 ECOG score
12.15 Estrogen Receptor status
12.16 Gleason score
12.17 Height
12.18 HER2 status
12.19 Histology
12.20 Pathological M-score
12.21 Pathological N-score
12.22 Pathological T-score
12.23 Pathological TNM group score
12.24 PR status
12.25 Regimen Careplan
12.26 Weight
12.27 ClinicalTrial
12.28 CourseNumber
12.29 CycleCount
12.30 CycleDay
12.31 CycleNumber
12.32 CyclePlannedLength
12.33 DoseAdjustmentReason
12.34 FacilityAdministered
12.35 IOT
12.36 LastAdminDate
12.37 PrescribedDose
12.38 RecurrenceType
12.39 Regimen type
12.40 RegimenDiscontinued
12.41 RegimenOTU
12.42 Basis of diagnosis
12.43 Clinical M score
12.44 Clinical N score
12.45 Clinical T score
12.46 Clinical TNM group
12.47 Dose adjustment reason
12.48 ECOG status
12.49 ER status
12.50 HER2 status
12.51 Histology
12.52 Intent of treatment
12.53 Is on a clinical trial
12.54 Outcome of a regimen
12.55 Pathological M score
12.56 Pathological N score
12.57 Pathological T score
12.58 Pathological TNM group
12.59 Patient factors when discontinuing a regimen
12.60 PR status
12.61 The reason why a regimen was discontinued
12.62 Toxicity reasons why a regimen was discontinued
12.63 Type of recurrence
12.64 bsa
12.65 careplan-regimen-1
12.66 careplan-regimen-2
12.67 Clinical M value
12.68 Clinical N value
12.69 Clinical T value
12.70 Clinical TNM group
12.71 CreatinineClearance
12.72 Cycle 1
12.73 ERStatus
12.74 Example practitioner
12.75 ExObservationECOG
12.76 ExObservationGleason
12.77 ExObservationHeight
12.78 ExObservationWeight
12.79 HER2Status
12.80 Histology: Small cell lung cancer
12.81 Lorrie Lung
12.82 medicationadministration-1
12.83 medicationrequest-1
12.84 Pathological M value
12.85 Pathological N value
12.86 Pathological T value
12.87 Pathological TNM group
12.88 PRStatus
12.89 Small cell lung cancer diagnosis